US Patent And Trademark Office Grants Azbil BioVigilant's Request
Azbil BioVigilant, Inc., inventors of Instantaneous Microbial Detection™, announced recently that the US Patent and Trademark Office (USPTO) has granted the Company’s request for reexamination of a patent which is the subject of a lawsuit filed against Azbil BioVigilant by TSI, Inc. Specifically, the USPTO rejected all claims of TSI’s patent because multiple prior art references taught the claimed elements, including the use of a laser diode. In addition to its invalidity positions, Azbil BioVigilant maintains that it does not infringe the TSI patent. TSI failed in a prior litigation filed in Minnesota against Azbil BioVigilant on the same patent, voluntarily dismissing that action.
Representing Azbil BioVigilant in its patent litigation is Amster, Rothstein & Ebenstein LLP.
About Azbil BioVigilant
With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous microbial detection technology to address environmental monitoring needs in the pharmaceutical, biotechnology, healthcare, and environmental applications. Azbil BioVigilant’s IMD systems detect - instantaneously and in real-time - particle count, size, and biological status. Unlike other rapid microbial methods, Azbil BioVigilant’s optically-based systems require no staining, no reagents, no waiting period, and little human intervention. The company holds 19 patents with an additional 37 applications pending. For more information, visit www.biovigilant.com.
About azbil Group
The azbil Group consists of Azbil Corporation and its affiliate and subsidiary companies. The azbil Group has operations in 15 countries worldwide, more than 8,000 employees, and sales of JPY 219.2 billion, as of March 31, 2011. For more information, visit www.azbil.com.
SOURCE: Azbil BioVigilant, Inc.